A former Pfizer employee has been convicted of insider trading after buying options in the company's stock prior to the announcement of positive Covid-19 drug data.
The employee, Amit Dagar, was a senior statistical program lead for the clinical trial of Pfizer's drug Paxlovid, which showed an 89% reduction in hospitalization or death compared to a placebo.